Monodeiodination of thyroxine to 3, 5, 3'-triiodothyronine and to 3, 3', 5'-triiodothyronine in isolated dog renal cortical tubuli

Monodeiodination of T4 to T3 and rT3 in the intact cells of dog renal tubuli and glomeruli was investigated. The tubuli and glomeruli were obtained by a sieve method. T4 (2 micrograms/ml) was incubated in Tris-HCl buffer, pH 7.5, with renal cells (180 micrograms protein/ml) and 5 mM DTT for 1 h at 37 degrees C and the T3 and rT3 generated during incubation were measured by specific radioimmunoassays. In order of decreasing activity, dog renal cortical tubuli, cortical homogenate, glomeruli and medullary tubuli were capable of converting T4 to T3. Net rT3 production from T4 in cortical tubuli was also greater than that in cortical homogenate. The conversion of T4 to T3 and also to rT3 in cortical tubuli was enzymatic in nature, since the reactions showed dependence on time and protein concentration; instability to heating; temperature and pH optimum. The production of T3 and rT3 from T4 was maximum at pH 6.5 and at pH 9.5, respectively, indicating that two different enzymic systems, a 5- and a 5'-monodeiodinase, might be involved in the deiodination of the tyrosyl and the phenolic ring of T4 in dog kidney.     

Conversion of thyroxine into 3,5,3'-triiodothyronine and 3,3',5'-triiodothyronine in the young pig

Estimates have been made of the amounts of 3,5,3'-triiodothyrone (T3) and 3,3',5'-triiodothyronine (rT3) derived from peripheral deiodination of thyroxine (T4) in young pigs. Two methods were used. The first depended on the assumption that deiodination occurs at the same rate in normal animals and in thyroidectomized animals on T4 replacement therapy. The second on the assumption that T3 and rT3 are secreted in the same proportions as they occur in thyroglobulin. The first method arguably gives the better estimate which is that 87% of circulating T4 is monodeiodinated to T3 and rT3. Peripheral conversion accounts for 76 and 69% of the circulating T3 and rT3, respectively.     

Radioimmunoelectrophoretic analysis of proteins binding 3, 3', 5'-triiodothyronine in human serum

The binding of purified 131I-3, 3', 5'-triiodothyronine (reverse T3) (rT3) to normal human serum components was investigated by a radioimmunoelectrophoretic technique. When anti-whole human serum was used, five distinct arcs of radioactivity were observed. Evidence was obtained that five of these radioactive arcs were not artifacts, but were due to components binding rT3. From the radioimmunoelectrophoretic patterns with specific antisera, five of these components were identified as thyroxine binding prealbumin, albumin, thyroxine binding globulin (TBG) and alpha 1-and beta-lipoproteins. No radioactive arc of TBG was detected in serum from a patient with TBG deficiency.     

Forskolin stimulation of 3, 5, 3'-triiodothyronine release from perifused rat thyroids

In a perifusion system in the presence of 3-isobutyl-1-methylxanthine, forskolin stimulated secretion of not only cAMP but also 3, 5, 3'-triiodothyronine (T3) from rat thyroid glands. The increases in both cAMP and T3 were dose-dependent at forskolin concentrations of 2.0 X 10(-7)M to 2.0 X 10(-5)M. After perifusion for 4 h, tissue concentrations of cAMP also increased as a result of forskolin treatment. Since forskolin is regarded as a specific activator of the cAMP generating system, this observed forskolin stimulation of T3 secretion from perifused rat thyroid glands indicates that cAMP is involved in regulating thyroid hormone secretion.     

The effect of adrenaline pretreatment on the in vitro generation of 3,5,3'-triiodothyronine and 3,3',5'-triiodothyronine (reverse T3) in rat liver preparation

The effects of adrenaline (A) on liver T3 and rT3 neogenesis from T4 were studied in Wistar rats. The animals were implanted subcutaneously either with A or placebo (P) especially coated tablets which linearly released the hormone. The serum A values 6 hrs after implantation of 7.5, 15.0 and 45.0 mg tablets were 6.5 +/- 1.31, 6.8 +/- 1.8 and 16.4 +/- 1.9 ng/ml, respectively vs 4.4 +/- 2.5 ng/ml seen in P pretreated group. The output rates of A were 0.11 (7.5 mg), 0.18 (15 mg) and 0.52 microgram/ml (45 mg). The pretreatment with A led to hyperglycemia and the "low T3 syndrome". Neogenesis of T3 from T4 in medium containing liver microsomes of P pretreated rats was 5.49 +/- 0.25 pmol of T3/mg protein/min and decreased in A pretreated rats to 3.82 +/- 0.17, 3.12 +/- 0.27 and 3.06 +/- 0.11 pmol of T3/mg of protein/min. Neogenesis of rT3 from T4 in microsomes from P group was 1.52 +/- 0.09 pmol rT3/mg protein/min and increased after A to 2.71 +/- 0.11, 2.60 +/- 0.21 and 2.21 +/- 0.34 pmol of rT3/mg protein/min thus showing no dose dependency. Enrichment of microsomes medium with cytosol either from P or A pretreated rats had no effect on T3 generation thus excluding effect of A on cytosolic cofactor. Although cytosol further increased rT3 neogenesis this was seen regardless of whether cytosol was obtained from A or P implanted rats. It is concluded that A decreases the activity of T4-5'-deiodinase in liver, and possibly increases the activity of T4-5-deiodinase.     

Studies on the presence of adenosine cyclic 3':5'-monophosphate in oat coleoptiles

The incorporation of adenosine-8-¹⁴C into adenosine cyclic 3′:5′-monophosphate in coleoptile-first leaf segments of Avena sativa L. was investigated. Homogenates of segments incubated in adenosine-8-¹⁴C for either 4 or 10 hours were partially purified by thin layer chromatography followed by paper electrophoresis. A radioactive fraction, less than 0.06% of the ¹⁴C present in the original homogenate, migrated as adenosine cyclic 3′:5′-monophosphate during electrophoresis. Upon treatment with cyclic nucleotide phosphodiesterase, however, less than 10% of this radioactive fraction appeared as 5′-AMP. Deamination with NaNO₂ as well as further chromatographical purification also suggested that only a small fraction of the ¹⁴C in the partially purified samples could be in adenosine cyclic 3′:5′-monophosphate. The data suggest that levels of this nucleotide can probably be no greater than 7 to 11 picomoles per gram of fresh weight in oat coleoptiles. Treatment of such coleoptiles with physiologically active concentrations of indoleacetic acid, furthermore, had no significant effect on the ¹⁴C radioactivity in marker adenosine cyclic 3′:5′-monophosphate-containing fractions at any stage of purification during several experiments.     

On the presence of 3H-GABA uptake mechanism in bovine spermatozoa

In the present study, existence of (3)H-GABA uptake mechanism in bovine spermatozoa and the modulation of (3)H-GABA transport by GABA itself were evaluated. The hypothesis was tyrosine phosphorylation affects transporter (GAT) function. (3)H-GABA uptake assays were performed on bovine spermatozoa and it resulted to be temperature- and time-dependent and K(m) was 1.48muM. Uptake was inhibited by the metabolic inhibitor ouabain and different blockers of GAT-1 (beta-alanine, l-DABA, nipecotic acid, tiagabine). Extracellular GABA up-regulated GABA transport, while the addition of SKF89976A, a high affinity inhibitor of the rat brain GABA transporter, reduced GABA uptake. Tyrosine phosphorylation affects transporter function since genistein, a broad-spectrum tyrosine kinase inhibitor, decreased (3)H-GABA uptake. Reduction in uptake did not occur in the presence of daidzein, an inactive genistein analogue. Furthermore, the genistein-mediated reduction in transport could be prevented by the tyrosine phosphatase inhibitor pervanadate. The action of these drugs on GABA transport is likely mediated through the GABA transporter GAT-1 since SKF89976A blocked a majority of GABA uptake. Wash-out experiments indicated that the genistein effect was reversible. When the experiments were conducted using "in vitro" capacitated spermatozoa there was no detectable uptake. Present results demonstrate that the carrier-mediated GABA uptake system in bovine spermatozoa modulates its function in response to extracellular GABA, that changes in lipid distribution and membrane composition which occur during capacitation eliminates GABA uptake and suggest the involvement of tyrosine phosphorylation in GABA transport.     

Conversion of thyroxine to 3,3',5'-triiodothyronine (reverse-T3) by a soluble enzyme system of rat liver

Infrared spectra of N₂O in a variety of solvents and in the brain of a dog under typical conditions of halothane-N₂O anesthesia have been determined. The appearance or disappearance of N₂O in the brain was readily followed as N₂O was administered or withdrawn. The sites in brain were of two major types; one, with ν₃ = 2229.8 ± 0.4 cm^?1 and $\text{Δν}{}_{\mathrm{<mtext>1</mtext><mtext>2</mtext>}}\text{= 13.0 ± 0.6}\text{cm}{}^{\mathrm{?1}}$, is rather like the polar site in water and the other, with ν₃ = 2216.8 ± 0.8 cm^?1 and $\text{Δν}{}_{\mathrm{<mtext>1</mtext><mtext>2</mtext>}}\text{= 9.6 ± 1.0}\text{cm}{}^{\mathrm{?1}}$, is non-polar and is probably associated with membrane lipid. The significant variations in the antisymmetric stretch (ν₃) of N₂O as the polarity and other properties of the medium (solvent) vary make possible the characterization of $\text{in tissue}$ sites occupied by this anesthetic.     

DNA synthesis and induced mutations in the presence of 5-bromouracil I. DNA synthesis in the presence of 5-bromouracil

Summary An investigation has been carried out dealing with the incorporation of BU into DNA ofE. coli 15 thy^– under conditions of complete thymine deficiency. It was found that exponentially growing cells can increase their DNA 5-fold upon suspension in BU-supplemented medium. DNA increased in a linear fashion and followed the series ×, 2×, 3×, 4× where × is the amount of DNA initially present. If thy^– cells were starved for 30 minutes before being provided with BU, DNA appeared to increase stepwise although the increase during each period of synthesis was equal only to the amount of DNA initially present. Paper chromatography revealed that BU totally replaced thymine in the newly-synthesized DNA. Equilibrium density gradient techniques and radioactive labeling made it possible to ascertain that the DNA in which BU fully replaced thymine was functional on the primary level, that of priming or taking iart in the synthesis of new DNA. Cellular inhibition as indicated by lethality was described and possible explanations for the inhibition resulting from incroporation of BU into DNA were discussed.